𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-α, C/EBP-β and C/EBP-δ in the human placenta

✍ Scribed by Ana-Maria Bamberger; Antonis Makrigiannakis; Martina Schröder; ChristophM. Bamberger; Constantine Relakis; Birgit Gellersen; Karin Milde-Langosch; Thomas Löning

Publisher
Springer
Year
2004
Tongue
English
Weight
297 KB
Volume
444
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced expression and DNA binding acti
Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPβ and C/EBPδ, in rheumatoid synovium
✍ Katsuhiro Nishioka; Shiro Ohshima; Mitsuko Umeshita-Sasai; Norihiko Yamaguchi; T 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 1 views

Objective. To investigate the activation and expression of CCAAT/enhancer-binding proteins (C/EBP), especially C/EBP␤ and -␦, in rheumatoid synovium, and their pathogenic implications in rheumatoid arthritis (RA). Methods. The activation of C/EBP␤ and -␦ was assessed in synovial tissues from patient

CCAAT/enhancer binding protein α (C/EBPα
CCAAT/enhancer binding protein α (C/EBPα) is an important mediator of mouse C/EBPβ protein isoform production
✍ Bonnie L. Burgess-Beusse; Nikolai A. Timchenko; Gretchen J. Darlington 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Both CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta are intronless, yet can create various N-terminally truncated protein products with distinct DNA binding and transactivation potentials. These proteins can be generated via two distinct mechanisms, one translational and the other p

CCAAT/enhancer binding protein δ (C/EBPδ
CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells: I. “Loss of function” alterations in the C/EBPδ growth inhibitory pathway in breast cancer cell lines
✍ G.S. Sivko; J.W. DeWille 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in

Inhibition of collagen gene expression b
Inhibition of collagen gene expression by interferon-γ: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ)
✍ Asish K Ghosh; Swati Bhattacharyya; Yasuji Mori; John Varga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

## Abstract By inhibiting collagen synthesis, interferon‐γ (IFN‐γ) plays a key role in maintaining connective tissue homeostasis, but the mechanisms are not well‐understood. In addition to intracellular signaling through the canonical JAK–STAT transduction pathway, IFN‐γ was recently shown to regul

Increased expression of the transcriptio
Increased expression of the transcription factors CCAAT-enhancer binding protein-B (C/EBB) and C/EBPζ (CHOP) correlate with invasiveness of human colorectal cancer
✍ Katarina Rask; Magnus Thörn; Fredrik Pontén; Wolfgang Kraaz; Karin Sundfeldt; La 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 211 KB 👁 2 views

Regulation of cell differentiation is most often impaired in malignant tumors and may represent a key mechanism for the progression of the disease. CCAAT-enhancer binding protein (C/EBP) is a family of transcription factors involved in the regulation of embryonic gut development in rodents, which ha

Expression of the liver-enriched transcr
Expression of the liver-enriched transcription factors C/EBPα, C/EBPβ, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver
✍ Per Flodby; De-Zhong Liao; Agneta Blanck; Kleanthis G. H. Xanthopoulos; Inger Po 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

## Abstract The expression patterns of the liver‐enriched transcription factors CCAAT/enhancer‐binding protein (C/EBP) α and β and hepatocyte nuclear factor (HNF)‐1 and HNF‐4 were studied in liver nodules and hepatocellular carcinomas from male rats treated according to the resistant hepatocyte (RH